Quanta Inc (fka QNTA)

[JediMozart]

https://jennifermargulis.substack.com/p/40000-deaths-but-no-recall?fbclid=IwAR3EEJeoWCcP6f7b5FNRdggnlRCTtySG3bbtAWlzFyxNWGeXnSNYDRBfzys

This article is yet Another plethora of reasons Why I personally use the immunipen DAILY … escozine, for myself, as I have had NO side affects, immunipen works as advertised - and I’ve personally avoided contracting Covid thus far & / or symptoms were reduced so much so I never knew I had it … the below article is great - what we know, escozine works, what we also know - MANY other Covid treatments seemingly do not …
The current share price is abysmal, I cannot deny that, however, on a health note the below article reminds us why we need more products / alternatives on the market to help combat Covid like escozine

https://jennifermargulis.substack.com/p/40000-deaths-but-no-recall?fbclid=IwAR3EEJeoWCcP6f7b5FNRdggnlRCTtySG3bbtAWlzFyxNWGeXnSNYDRBfzys

https://medoliferx.com/shop/drops/escozine-immunapen-original-drops/

[{“On June 29, 2022, Dr. Peter McCullough, M.D., testified to the Texas Senate Health and Human Services Committee about what we have learned during the COVID-19 pandemic. He called his 17-minute presentation “Pandemic Lessons Learned.”

Who is Peter McCullough, M.D.?

Peter McCullough is one of the country’s best published and most respected cardiologists. He has practiced conventional cardiology throughout his successful career and never had a reason to question medical authority or vaccine safety. All of that changed during COVID. As he explained to the same committee in March of 2021 (you can find a transcript of that testimony on my website), McCullough was deeply disturbed that the medical establishment insisted COVID wasn’t treatable.

You can read the full transcript of his testimony below. But for anyone who wants the cheat sheet…

The Most Important Take-aways:

1. COVID-19 is treatable. Early treatment reduces your risk of hospitalization and death by 95 percent, according to Dr. McCullough.

2. Remdesivir is not a safe or effective drug and should not be used to treat COVID-19

3. Vaccines against COVID-19 were not adequately studied before being made available to the public.

4. COVID-19 vaccine program should be immediately halted worldwide.

5. Doctors, nurses, and patients who share their stories should not be censored or vilified. We need to pay attention to their experiences, not seek to silence them.

Pandemic Lessons Learned

Dr. Peter McCullough: Madam chairman, ladies and gentlemen: I am probably well known to the committee, I testified here on March 10th, 2021. I’m a practicing internist and cardiologist in Dallas, Texas, and I'm an expert on COVID-19.

I have 56 peer-reviewed publications on the pandemic. Particularly, on how to treat the infection, and over 770 overall publications in the National Library of Medicine, and well over a thousand overall medical communications.

I’ve served on two dozen data-safety monitoring boards for large pharmaceutical and device and in vitro diagnostic studies; and I consider myself both an expert on the COVID-19 virus as well as on drug and device and biological agents safety.

Here are my comments.

A Duty to Treat the Patient

There has always been a duty to treat COVID-19. It started with the very first case—as soon as we recognized that this was a potentially fatal infection.

When a patient could have died of this infection, at that moment, and we understood it early based on risk stratification (based on age, medical problems, and severity of symptoms upon presentation), there was a duty to treat that patient. Period.

If a doctor did not treat that patient when a patient sought help, there was a duty to refer. From the very beginning, there was a community standard of care—though from the very beginning, it evolves over time. In many situations like this or with rare diseases, the community standard of care may be one doctor in that community who's going to take on the challenge of treating that patient—but that becomes the community standard of care.

Early, there was use of a variety of drugs that became standard of care, as evidenced by surges in use of these drugs, and they included hydroxychloroquine, ivermectin, prednisone, and budesonide. There were giant surges and use of these drugs as evidence that these were outpatient evolving standards of care.

Now there is surge of use in Paxlovid and a minor surge in Molnupiravir.

There has always been a community standard of care for early treatment.

Lessons learned for this committee. There have been eight hours of testimony today. [But] not a single presenter could tell you what patients in these data sets received early treatment and what was their outcomes. Not a single presenter knew who had received early treatment and what was the degree of complexity of that early treatment.

Next Time We Must Convene an Early Treatment Committee

Lesson learned. Next pandemic immediately get an outpatient early treatment committee together. Their objective is to reduce the risk of hospitalization and death. That is the overall objective of this pandemic: Keep people out of the hospital and keep them alive. If they can get through this illness at home, that was your mission from the very beginning on early treatment.

Fortunately, there have now been about 1,400 studies. There have been hundreds and hundreds of randomized trials. And we know that sequenced multi-drug therapy that addresses viral replication, inflammation, or cytokine storm and thrombosis is the approach in handling this.

Dr. Procter is here. He's published two very good studies right from the state of Texas. Dr. Vladimir Zelenko in Monroe, New York. Dr. Raoult in France.

All the data are cohesive: that the early protocols—the very early—had 85 percent reductions in the risk of hospitalization and death.

Early Treatment Reduces Risk of Death by 95 Percent

Now with monoclonal antibodies, Paxlovid, and others, I've testified under oath in the U.S. Senate on January 24th, 2022, based on my expert opinion there is now a 95 percent risk reduction for death and hospitalization if early treatment is provided.

Conversely, I've reviewed hundreds if not thousands of reports of patients who were hospitalized and died. Hundreds, if not thousands of reports. The real outcome of hospitalization and death is a product of not receiving early treatment.

Whether someone's vaccinated or not, the vaccination is irrelevant because the vaccination is not a treatment.

What's relevant is: Was the patient treated before the hospital? And every single case, and in every single patient outcome that I can see, the reason why they were in the hospital is they received either zero outpatient treatment or they received inadequate treatment that was received too late.

So a committee like this lesson learned: it's always going to be about treating the next infectious disease early.

In terms of inpatient care and the overall landscape of what happened timeline, I think the charge of the committee is pay attention to big developments! Pay attention to these.

In May of 2020, there was a U.S. Senate hearing on the use of corticosteroids. Pay attention to that … You heard confusing testimony. Some of these doctors didn't know if steroids worked or not. That was a landmark event, where it was clear that steroids worked, and it should have rapidly been instituted as a standard of care in the hospital.

Another giant development was I had published the first overall treatment protocol paper in a major medical journal, August 7th of 2020, but rapidly after that in September of 2020 there already was a home treatment guide by the Association of American Physicians and Surgeons. When there is a physician group that publishes a home treatment guide, pay attention to that.

Remember the Infectious Disease Society of America always had the first set of guidelines and then the NIH. They still to this day do not have a comprehensive outpatient treatment guideline.

That's the reason why AAPS filled in, Frontline Critical Care Network filled in, Truth for Health Foundation, Frontline Doctors, and others. When other physician organizations based on consensus and data fill in the gaps, pay attention to that. Very very important.

Remdesivir Responsible for Kidney, Liver Injury

When an organization puts out a negative position on a drug. A negative position. This is really important and it's a worldwide organization, you must pay attention to this.

November of 2020, the World Health Organization says stop using remdesivir. Stop it! It's bad. It doesn't work and it’s leading to more deaths, it leads to kidney injury and liver injury.

The immediate thing this committee should have done is [address who's using remdesivir in the state of Texas and let's talk about it.

Now whether or not the NIH disagrees with it or the WHO, that’s got to be vetted, but the question should have been asked. We needed to reexamine this. Were Texans going to be hurt by this drug?

The World Health Organization, European Society of Critical Care said yes [people were hurt by remdesivir]. And that went on under this committee's watch.

These are very very important. Lesson learned. Pay attention to the big developments.

We've covered monoclonal antibodies well enough.”}]